Evolocumab 140mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £72,466,342 of indicative cost of Evolocumab 140mg/1ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is up 58.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Evolocumab 140mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Evolocumab 140mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Hampshire Hospitals Nhs Foundation Trust | £41,652,047 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,220,826 |
| Manchester University Nhs Ft | £1,536,173 |
| University Hpls Of Leicester Nhs Trust | £1,238,158 |
| Univ Hpls Bristol Nhs Foundation Trust | £975,864 |
| Sheffield Teaching Hospitals Nhs Trust | £845,397 |
| Gloucestershire Hpls Nhs Foundation Trst | £777,527 |
| Imperial College Healthcare Nhs Trust | £769,703 |
| Univ Hpl B/Ham Nhs Foundation Trust | £755,754 |
| Aintree University Hospital Nhs Ft | £726,327 |
The primary-care picture
Evolocumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Evolocumab medicine page.